ACNM Annual Meeting Track - "The Latest & Greatest"

The ACNM 2021 Annual Meeting track will feature a robust program of cutting-edge educational content and oral presentations, highlighted by John A. Katzenellenbogen, PhD, who will present the Mandell-Alavi Plenary Session. In addition, all meeting attendees are invited to attend ACNM Awards Ceremony and Banquet on Friday evening. During this event the ACNM will honor its 2021 ACNM Lifetime Achievement Award Winner, 2021 Gold Medal Award winner, present the ACNM Abstract Awards; and induct its 2021 Class of Fellows.

Full Session Continuing Education Details | How to Earn CE Credits
For Faculty and Planner Financial Disclosure Information, please click here.


Thursday, January 28

2:00–2:30 pm ET

Opening/Welcome Session

2:30–4:30 pm ET

ACNM Oral Abstract Presentations
Organizer:  Simin Dadparvar, MD, FACNM

4:45–6:45 pm ET

ACNM Oral Abstract Presentations
Organizer:  Simin Dadparvar, MD, FACNM

Friday, January 29

10:00–11:30 am ET

ACNM’s President’s Session
Sponsored by the ACNM
Organizer:  Yang Lu, MD, PhD, FACNM
Moderator: Yang Lu, MD, PhD, FACNM

Session Description
This session will focus on the up-to-date research and current clinical practice of nuclear medicine.
 
Session Objectives
  1. Discuss ACNM’s efforts and initiatives in 2020; ACNM’s vision and resolution for the years to come.
  2. Describe the perspectives of  nuclear medicine leaders about the future of nuclear medicine, joined by live discussions.
  3. Examine the newly FDA approved FES PET tracer, and its impact on nuclear medicine practices.

Presentations Include:

  • ACNM in the Era of Theranostics: Stay Current and Keep Advancing
    Yang Lu, MD, PhD, FACNM
  • Nuclear Medicine and Molecular Imaging in the Last Two Decades:  Lessons Learned and Future Directions
    Rathan Subramaniam, MD, PhD, MPH, FACNM, FSNMMI
  • PET Imaging of Estrogen Receptors in Breast Cancer
    David A. Mankoff, MD, PhD
  • Panel Discussion & Q/A w/ Speakers 


11:45 am–1:15 pm ET

Mandell-Alavi Award Session
Sponsored by the ACNM
Organizer: Gary Ulaner, MD, PhD, FACNM; Bital Savir-Baruch, MD
Moderator: Gary Ulaner, MD, PhD, FACNM

Session Description
This session introduces the newly approved FES PET/CT tracer in the imaging of breast cancer.

Session Objectives

  1. Participate in the introduction of [18]F-fluoroestradiol
  2. Discuss the clinical use of [18]F-fluoroestradiol
  3. Describe the [18]F-fluoroestradiol effect on clinical management

Presentations Include:

  • Introduction of FES PET/CT
    Farrokh Dehdashti, MD
  • The Mandell-Alavi Award Lectureship:  FES and FFNP PET Imaging in Breast Cancer: A Single Goal in an Ever-Changing Landscape
    John A. Katzenellenbogen, PhD
  • Panel Discussion & Q/A w/ Speakers


2:15–3:45 pm ET

Operationalizing Genetic and Molecular Characterization in the Management of Differentiated Thyroid Cancer
Sponsored by the ACNM
Organizer: Mark Tulchinsky, MD, CCD, FACNM, FSNMMI
Moderator: Alan Klitzke, MD, FACNM

Session Description
This session will discuss the importance of genetic mutations and thyroid cancer treatment.

Session Objectives

  1. Discuss common practice with thyroid cancer management
  2. Examine the importance of genetic mutation in the management of thyroid cancer
  3. Describe targeted therapy of differentiator thyroid cancer

Presentations Include:

  • Genomic and Molecular Principles of Theranostic Surgical Management of Differentiated Thyroid Cancer
    Seza A. Gulec, MD, FACS, FACNM
  • Integration of Genetic Mutations into Theranostic Nuclear Medicine
    Mark Tulchinsky, MD, FACNM, FSNMMI
  • Targeted Therapy in Thyroid Cancer:  Reversal of Fortune
    Seza A. Gulec, MD, FACS, FACNM
  • Metabolic and Molecular Characterization of Differentiated Thyroid Cancer for Thera-Nuclear Management
    Mark Tulchinsky, MD, FACNM, FSNMMI
  • Panel Discussion & Q/A w/ Speakers


4:15–5:45 pm ET

ACNM International Session: The Latest and Greatest Around the Globe
Sponsored by the ACNM
Organizer: Twyla B. Bartel, DO, MBA, FACNM
Moderator: Twyla B. Bartel, DO, MBA, FACNM

Session Description
This year, the ACNM would like to reaffirm its support of women in science in the annual international session.  Presented will be a few topics of the latest use of nuclear medicine in their respective countries.  The intended audience is for all nuclear medicine specialists.

Session Objectives

  1. Share the experience of treating patients with peptide receptor radionuclide therapy in an Asian population.
  2. Demonstrate how Ga68 PSMA imaging is an invaluable tool to investigate the biological behavior of prostate cancer.
  3. Gain insights into the theranostic use of radionanomedicine.

Presentations Include:

  • Clinical Outcome of PRRT for Neuroendocrine Tumors in Asian Population
    Dr. Wei Ying Tham (AOFNMB - Singapore) 
  • Ga68 PSMA:  Changing the Imaging Paradigm in Prostate Cancer
    Dr. Ishita Sen (india) 
  • Theranostic Use of Radionanomedicine
    Dr. So Won Oh (Korea)
  • Panel Discussion & Q/A w/ Speakers


6:00–7:30 pm ET

Case-Based Summary and Review, Read with the Experts
Sponsored by the ACNM
Organizer: Twyla B. Bartel, DO, MBA, FACNM; Bital Savir-Baruch, MD; Tracy L. Yarbrough, PhD, MD, MAEd, FACNM
Moderator: Twyla B. Bartel, DO, MBA, FACNM; Bital Savir-Baruch, MD; Tracy L. Yarbrough, PhD, MD, MAEd, FACNM

Session Description
In this session, the speakers will present SAM formatted collection of questions written by different nuclear medicine experts.

Session Objectives

  1. Describe the clinical use of 18F-fluoroestradiol, 18F-fluciclovine, 68G- DOTA-TATE radiopharmaceuticals.
  2. Discuss the clinical approach to theranostics with highlight to lutetium Lu 177 dotatate and I131.
  3. Review radiopharmaceutical uptake patterns in oncology scans.


Presentations Include:

  • Case-Based Summary and Review, Read with the Experts
    Twyla B. Bartel, DO, MBA, FACNM; Bital Savir-Baruch, MD; Tracy L. Yarbrough, PhD, MD, MAEd, FACNM
  • Panel Discussion & Q/A w/ Speakers